Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FATVT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,064
Award facts
- Contract value 100% obligated
- $13,063.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $13,063.81 to DMS Pharmaceutical Group Inc. for Dupixent (dupilumab) 300 mg/2 mL pens on October 17, 2025, with completion targeted for October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under firm fixed-price terms with no set-aside designation, indicating competitive award. The product will be delivered to Conshohocken, Pennsylvania.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to supply the Department of Defense with a comprehensive range of pharmaceutical products and medical consumables to support military healthcare facilities worldwide. The underlying IDC, awarded November 13, 2025, carries a $500 million ceiling and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical pharmaceutical supplier within the federal military medical supply chain with the capability to fulfill diverse and specialized pharmaceutical requirements across DOD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FATVT?
SPE2DB26FATVT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FATVT worth?
The government has obligated $13,064 on SPE2DB26FATVT.
Is contract SPE2DB26FATVT an order under another contract?
Yes. SPE2DB26FATVT is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATVT competed?
The extent of competition for SPE2DB26FATVT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award